[HTML][HTML] Molecular methods for somatic mutation testing in lung adenocarcinoma: EGFR and beyond
C Khoo, TM Rogers, A Fellowes, A Bell… - … lung cancer research, 2015 - ncbi.nlm.nih.gov
Somatic mutational profiling in cancer has revolutionized the practice of clinical oncology. The
discovery of driver mutations in non-small cell lung cancer (NSCLC) is an example of this. …
discovery of driver mutations in non-small cell lung cancer (NSCLC) is an example of this. …
[HTML][HTML] Homologous recombination repair deficiency: An overview for pathologists
The repair of DNA double-stranded breaks relies on the homologous recombination repair
pathway and is critical to cell function. However, this pathway can be lost in some cancers …
pathway and is critical to cell function. However, this pathway can be lost in some cancers …
UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas
Merkel cell carcinoma (MCC) is an uncommon, but highly malignant, cutaneous tumor. Merkel
cell polyoma virus (MCV) has been implicated in a majority of MCC tumors; however, viral-…
cell polyoma virus (MCV) has been implicated in a majority of MCC tumors; however, viral-…
Informing the NHS Outcomes Framework: evaluating meaningful health outcomes for children with neurodisability using multiple methods including systematic review …
…, V Shilling, R Tomlinson, J Williams, A Fellowes… - 2014 - ore.exeter.ac.uk
Background The identification of suitable outcome measures will improve the evaluation of
integrated NHS care for the large number of children affected by neurodisability, and has the …
integrated NHS care for the large number of children affected by neurodisability, and has the …
Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing
Background Clinical specimens undergoing diagnostic molecular pathology testing are fixed
in formalin due to the necessity for detailed morphological assessment. However, formalin …
in formalin due to the necessity for detailed morphological assessment. However, formalin …
First-in-human RNA polymerase I transcription inhibitor CX-5461 in patients with advanced hematologic cancers: results of a phase I dose-escalation study
…, E Link, P Blombery, ER Thompson, A Fellowes… - Cancer discovery, 2019 - AACR
CX-5461 is a first-in-class selective inhibitor of rDNA transcription. This first-in-human study
establishes the feasibility of targeting this process, demonstrating single-agent antitumor …
establishes the feasibility of targeting this process, demonstrating single-agent antitumor …
[HTML][HTML] Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants
…, S Eggers, E Eyras, MF Fernandez, A Fellowes… - Genetics in …, 2022 - Elsevier
Purpose Genetic variants causing aberrant premessenger RNA splicing are increasingly
being recognized as causal variants in genetic disorders. In this study, we devise standardized …
being recognized as causal variants in genetic disorders. In this study, we devise standardized …
Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary
…, T Siganakis, P Cowin, A Fellowes… - The Journal of …, 2013 - Wiley Online Library
The clinical management of patients with cancer of unknown primary ( CUP ) is hampered
by the absence of a definitive site of origin. We explored the utility of massively‐parallel (next‐…
by the absence of a definitive site of origin. We explored the utility of massively‐parallel (next‐…
Dual targeting of CDK4/6 and BCL2 pathways augments tumor response in estrogen receptor–positive breast cancer
Purpose: Although cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors significantly extend
tumor response in patients with metastatic estrogen receptor–positive (ER + ) breast cancer, …
tumor response in patients with metastatic estrogen receptor–positive (ER + ) breast cancer, …
Key health outcomes for children and young people with neurodisability: qualitative research with young people and parents
A Allard, A Fellowes, V Shilling, A Janssens… - BMJ open, 2014 - bmjopen.bmj.com
Objectives To identify key health outcomes, beyond morbidity and mortality, regarded as
important in children and young people with neurodisability, and their parents. Design …
important in children and young people with neurodisability, and their parents. Design …
